[HTML][HTML] Investigating associations between blood metabolites, later life brain imaging measures, and genetic risk for Alzheimer's disease

RE Green, J Lord, MA Scelsi, J Xu, A Wong… - Alzheimer's research & …, 2023 - Springer
Background Identifying blood-based signatures of brain health and preclinical pathology
may offer insights into early disease mechanisms and highlight avenues for intervention …

Investigating associations between blood metabolites, later life brain imaging measures, and genetic risk for Alzheimer's disease

RE Green, J Lord, MA Scelsi, J Xu… - Alzheimer's …, 2023 - search.proquest.com
Background Identifying blood-based signatures of brain health and preclinical pathology
may offer insights into early disease mechanisms and highlight avenues for intervention …

[HTML][HTML] Investigating associations between blood metabolites, later life brain imaging measures, and genetic risk for Alzheimer's disease

RE Green, J Lord, MA Scelsi, J Xu… - Alzheimer's …, 2023 - alzres.biomedcentral.com
Identifying blood-based signatures of brain health and preclinical pathology may offer
insights into early disease mechanisms and highlight avenues for intervention. Here, we …

[引用][C] Investigating associations between blood metabolites, later life brain imaging measures, and genetic risk for Alzheimer's disease

RE Green, J Lord, MA Scelsi, J Xu… - Alzheimers …, 2023 - espace.library.uq.edu.au
BackgroundIdentifying blood-based signatures of brain health and preclinical pathology
may offer insights into early disease mechanisms and highlight avenues for intervention …

[PDF][PDF] Investigating associations between blood metabolites, later life brain imaging measures, and genetic risk for Alzheimer's disease

RE Green, J Lord, MA Scelsi, J Xu, A Wong… - 2023 - core.ac.uk
Background Identifying blood‑based signatures of brain health and preclinical pathology
may offer insights into early disease mechanisms and highlight avenues for intervention …

Investigating associations between blood metabolites, later life brain imaging measures, and genetic risk for Alzheimer's disease

R Green, J Lord, MA Scelsi, J Xu, A Wong… - medRxiv, 2022 - medrxiv.org
Identifying blood-based signatures of brain health and preclinical pathology may offer
insights into early disease mechanisms and highlight avenues for intervention. Here, we …

Investigating associations between blood metabolites, later life brain imaging measures, and genetic risk for Alzheimer's disease.

RE Green, J Lord, MA Scelsi, J Xu… - Alzheimer's …, 2023 - search.ebscohost.com
Background: Identifying blood-based signatures of brain health and preclinical pathology
may offer insights into early disease mechanisms and highlight avenues for intervention …

[HTML][HTML] Investigating associations between blood metabolites, later life brain imaging measures, and genetic risk for Alzheimer's disease

R Green, J Lord, MA Scelsi, J Xu, A Wong… - 2022 - europepmc.org
Identifying blood-based signatures of brain health and preclinical pathology may offer
insights into early disease mechanisms and highlight avenues for intervention. Here, we …

Investigating associations between blood metabolites, later life brain imaging measures, and genetic risk for Alzheimer's disease

RE Green, J Lord, MA Scelsi, J Xu… - … research & therapy, 2023 - pubmed.ncbi.nlm.nih.gov
Background Identifying blood-based signatures of brain health and preclinical pathology
may offer insights into early disease mechanisms and highlight avenues for intervention …

Investigating associations between blood metabolites, later life brain imaging measures, and genetic risk for Alzheimer's disease

Insight 46 study team - Alzheimer's …, 2023 - researchinformation.amsterdamumc …
Background: Identifying blood-based signatures of brain health and preclinical pathology
may offer insights into early disease mechanisms and highlight avenues for intervention …